Literature DB >> 30511885

Outcomes and Long-Term Follow-Up with the Use of Ureteral Access Sheath for Pediatric Ureteroscopy and Stone Treatment: Results from a Tertiary Endourology Center.

Ravindar Anbarasan1, Stephen J Griffin1, Bhaskar K Somani2.   

Abstract

PURPOSE: The aim of this study was to retrospectively analyze outcomes of flexible ureteroscopy and laser fragmentation (FURSL) of renal stones with the use of ureteral access sheath (UAS) in the pediatric population.
MATERIALS AND METHODS: We retrospectively collected data between January 2011 and January 2018 for patient demographics, stone characteristics, and outcomes in 21 children who underwent FURSL with the use of UAS.
RESULTS: Twenty-one patients (10 boys and 11 girls) with a mean age of 11.8 years (range: 2-16 years) underwent FURSL using an access sheath. The stone location was in the lower pole in 13 patients (62%) with 12 patients (57%) having multiple stones. A 9.5F (35 cm) Cook Flexor UAS was used in all cases. The mean and overall stone size was 12 mm (range: 5-30 mm) and 15.4 mm (range: 5-35 mm), respectively. Preoperative stent was present in 8(38%) patients, and a postoperative stent or overnight ureteric catheter was inserted in 14 patients (67%). Thirty-one procedures (average: 1.5/patient) were needed to achieve a stone-free rate of 95%. There were no procedural or long-term complications noted over a mean follow-up of 26 months (4-37 months).
CONCLUSION: The use of UAS in the treatment of pediatric renal stones is safe and feasible with good outcomes and without any long-term sequelae.

Entities:  

Keywords:  flexible ureteroscopy; lasertripsy; pediatrics; ureteral access sheath

Mesh:

Year:  2019        PMID: 30511885     DOI: 10.1089/end.2018.0448

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  7 in total

Review 1.  Pictorial review of tips and tricks for ureteroscopy and stone treatment: an essential guide for urologists from PETRA research consortium.

Authors:  Bhaskar K Somani; Achilles Ploumidis; Athanasios Pappas; Steeve Doizi; Omikunle Babawale; Laurian Dragos; Emre Sener; Michele Talso; Tzevat Tefik; Peter Kronenberg; Esteban Emiliani; Luca Villa; Guido Kamphuis; Silvia Proietti; Olivier Traxer
Journal:  Transl Androl Urol       Date:  2019-09

2.  Laser access and utilization preferences for pediatric ureteroscopy: A survey of the Societies of Pediatric Urology.

Authors:  Ray Yong; Gregory E Tasian; Kate H Kraft; William W Roberts; Adam Maxwell; Jonathan S Ellison
Journal:  Can Urol Assoc J       Date:  2022-03       Impact factor: 1.862

Review 3.  Role of Pediatric Ureteral Access Sheath and Outcomes Related to Flexible Ureteroscopy and Laser Stone Fragmentation: A Systematic Review of Literature.

Authors:  Francesco Ripa; Theodoros Tokas; Stephen Griffin; Stefania Ferretti; Anna Bujons Tur; Bhaskar K Somani
Journal:  Eur Urol Open Sci       Date:  2022-10-12

4.  Impact of ureteral access sheath on renal stone treatment: prospective comparative non-randomised outcomes over a 7-year period.

Authors:  Ashleigh Lima; Thomas Reeves; Robert Geraghty; Amelia Pietropaolo; Lily Whitehurst; Bhaskar K Somani
Journal:  World J Urol       Date:  2019-07-24       Impact factor: 4.226

5.  Small Ureteral Access Sheath in Treating Paediatric Urolithiasis: A Single Centre Experience.

Authors:  Sahar Aljumaiah; Nasser Allubly; Ahmad Alshammari; Mohammad Alkhamees; Saeed Bin Hamri
Journal:  Res Rep Urol       Date:  2020-12-22

Review 6.  Does ureteral access sheath have an impact on ureteral injury?

Authors:  Mehmet Kazim Asutay; Marco Lattarulo; Despoina Liourdi; Abdulrahman Mohamed Al-Aown; Konstantinos Pagonis; Noor Nedal; Amelia Pietropaolo; Esteban Emiliani; Evangelos Liatsikos; Panagiotis Kallidonis
Journal:  Urol Ann       Date:  2022-01-20

7.  Flexible ureteroscopy and laser lithotripsy for renal stones 2 cm or greater: A single institutional experience.

Authors:  Jian-Sheng Huang; Jing Xie; Xiang-Jiang Huang; Qian Yuan; Hong-Tao Jiang; Ke-Feng Xiao
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.